Fluidigm has released a low-cost range of assays and primers optimised for the company's integrated fluidic circuit technology.
Fluidigm assays and target-specific primers enable customers to create highly multiplexed panels using off-the-shelf and custom content focused on their particular research areas.
As part of the programme, Fluidigm will provide the assay primer locus sequences with every order.
The products are being marketed as Deltagene assays (gene expression), SNPtype assays (SNP genotyping) and access array target-specific primers (target enrichment for next-generation sequencing).
In addition, the company is offering a catalogue of biologically grouped quantitative PCR assays that researchers can customise into panels.
SNPtype assays offer a low-cost SNP genotyping solution.
Assays are made on demand and are ready to meet high-throughput needs for a range of agricultural applications and the confirmation of next-generation sequencing results.
Access array target-specific primers provide an easy way for customers to generate sequencer-ready amplicons for next-generation sequencing.
Currently, Fluidigm offers custom PCR-based primer design for human- and mouse-targeted resequencing.
The company provides sufficient volumes of assay and primer solution to run hundreds of Fluidigm chips at costs substantially lower than competing products.
Fluidigm has simple-to-use protocols that save customers time and effort.
This allows researchers to spend less time on assay development and more time gathering results and publishing quickly.
